Citadel Advisors’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132M | Buy |
1,396,644
+1,052,924
| +306% | +$99.6M | 0.02% | 195 |
|
|
2025
Q1 | $21.8M | Sell |
343,720
-1,008,993
| -75% | -$64.1M | ﹤0.01% | 848 |
|
|
2024
Q4 | $62.8M | Buy |
1,352,713
+174,691
| +15% | +$8.11M | 0.01% | 442 |
|
|
2024
Q3 | $33.9M | Buy |
1,178,022
+1,075,407
| +1,048% | +$30.9M | 0.01% | 633 |
|
|
2024
Q2 | $1.48M | Sell |
102,615
-39,597
| -28% | -$573K | ﹤0.01% | 2699 |
|
|
2024
Q1 | $2.29M | Buy |
142,212
+114,022
| +404% | +$1.83M | ﹤0.01% | 2377 |
|
|
2023
Q4 | $560K | Sell |
28,190
-148,293
| -84% | -$2.95M | ﹤0.01% | 3622 |
|
|
2023
Q3 | $2.88M | Sell |
176,483
-109,383
| -38% | -$1.78M | ﹤0.01% | 2064 |
|
|
2023
Q2 | $6.04M | Buy |
285,866
+17,618
| +7% | +$372K | ﹤0.01% | 1569 |
|
|
2023
Q1 | $5.39M | Buy |
+268,248
| New | +$5.39M | ﹤0.01% | 1756 |
|
|
2022
Q4 | – | Sell |
-695,260
| Closed | -$7.11M | – | 6774 |
|
|
2022
Q3 | $7.11M | Buy |
695,260
+684,511
| +6,368% | +$7M | ﹤0.01% | 1554 |
|
|
2022
Q2 | $45K | Buy |
+10,749
| New | +$45K | ﹤0.01% | 5536 |
|
|
2022
Q1 | – | Sell |
-11,889
| Closed | -$80K | – | 7185 |
|
|
2021
Q4 | $80K | Sell |
11,889
-10,981
| -48% | -$73.9K | ﹤0.01% | 6014 |
|
|
2021
Q3 | $125K | Buy |
+22,870
| New | +$125K | ﹤0.01% | 5713 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7161 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6859 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5632 |
|
|
2019
Q2 | – | Sell |
-10,824
| Closed | -$68K | – | 5144 |
|
|
2019
Q1 | $68K | Buy |
+10,824
| New | +$68K | ﹤0.01% | 4168 |
|